AG00ABJH

153504-70-2 | rel-(2R,3'R)-2-Methyl-1'-azaspiro[[1,3]oxathiolane-5,3'-bicyclo[2.2.2]octane] hydrochloride hydrate

Chemical structure of rel-(2R,3'R)-2-Methyl-1'-azaspiro[[1,3]oxathiolane-5,3'-bicyclo[2.2.2]octane] hydrochloride hydrate, CAS 153504-70-2
AG00ABJH
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 153504-70-2
Catalog Number AG00ABJH(AGN-PC-0Q6J69)
Chemical Name rel-(2R,3'R)-2-Methyl-1'-azaspiro[[1,3]oxathiolane-5,3'-bicyclo[2.2.2]octane] hydrochloride hydrate
IUPAC Name (5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane];hydrate;dihydrochloride
InChI InChI=1S/2C10H17NOS.2ClH.H2O/c2*1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11;;;/h2*8-9H,2-7H2,1H3;2*1H;1H2/t2*8?,10-;;;/m11.../s1
InChI Key ZSTLCHCDLIUXJE-MMPAUJBDSA-N
MDL Number MFCD01759988
Molecular Formula C20H38Cl2N2O3S2
Molecular Weight 489.5633
SMILES C[C@@H]1O[C@]2(CS1)[C@H]3CCN(CC3)C2.C[C@@H]4O[C@]5(CS4)[C@H]6CCN(CC6)C5.Cl.O.Cl
Synonyms
2-methyspiro(1,3-oxathiolane-5,3)quinuclidine, AF 102B, AF 102B, (cis-(+))-isomer, AF 102B, (trans)-isomer, AF-102B, AF102B, cevimeline, cevimeline hydrochloride, Evoxac, FKS 508, FKS-508, SNI 2011, SNI-2011, Cevimeline hydrochloride hemihydrate, 153504-70-2, Cevimeline (hydrochloride hemihydrate), Cevimelinehydrochloride, (+)-Cevimeline hydrochloride hemihydrate, (-)-Cevimeline hydrochloride hemihydrate, SNI-2011, 2C10H17NOS.2ClH.H2O, 1462862-74-3, MFCD01759988, API0004800, X6142, W-5273, 504C702, Cevimeline hydrochloride, Cevimeline HCl 1/2H2O, UNII-P81Q6V85NP, Cevimeline hydrochloride [USAN], AF-102B, C10H17NOS.ClH.1/2H2O, 2569H, C10-H17-N-O-S.Cl-H.1/2H2-O, cis-2-Methylspiro(1,3-oxathiolane-5,3')quinuclidine hydrochloride hydrate (2:2:1), N/A,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited